Potassium Phosphate, Monobasic has 5 known drug interactions based on U.S. FDA drug labeling data. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Potassium Supplements, Antacids Containing Aluminum, Antacids Containing Magnesium. Patients taking Potassium Phosphate, Monobasic should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 5
- Major
- 1
- Moderate
- 4
Major (1)
- Potassium Phosphate, Monobasic + Potassium Supplements— Concurrent use may cause hyperkalemia. Serum potassium levels should be monitored periodically.
Moderate (4)
- Potassium Phosphate, Monobasic + Antacids Containing Aluminum— Aluminum in antacids may bind phosphate and prevent its absorption.
- Potassium Phosphate, Monobasic + Antacids Containing Magnesium— Magnesium in antacids may bind phosphate and prevent its absorption.
- Potassium Phosphate, Monobasic + Calcium Antagonists— Calcium in antacids may bind phosphate and prevent its absorption.
- Potassium Phosphate, Monobasic + Salicylates— May increase serum salicylate levels due to reduced excretion in acidified urine. Serum levels should be closely monitor…